PLA2R1 and nephrotic syndrome: Interestingly, the patients from the group that had anti-PLA2R antibodies negativization at three months but did not reach remission had more severe nephrotic syndrome and higher chronicity score on kidney biopsy than those who reached remission and had positive antibodies after three months (S1 Table S3).